Stabilizing and Protecting Solutions

SPS® Formulation Platform

  • SPS® meet current and emerging needs of our partners in the fields of proteins, biologics, biosimilars, and vaccines as well as drug delivery systems and medical devices or combinations thereof

Our proprietary Stabilizing and Protecting Solutions (SPS®) platform provides next generation formulation technologies to increase stability and protection of therapeutic proteins in dry and liquid formulations

Back

Stabilizing and Protecting solutions platform

Thermal Stabilization Platform

More Information

Features

  • allows for uncooled storage and distribution
  • prolongs shelf life
  • for dry and liquid formulations of biologics incl. high concentration formulations

Benefits

  • realizes cost savings
  • opens new regional markets
  • meets the needs of more and new patients
  • realizes full product potential

Sterilization Protection Platform

More Information

Features

  • allows for terminal sterilization
  • for dry formulations of biologics including peptide-based antibiotics & enzymes
  • meets regulatory requirements

Benefits

  • no need for aseptic production
  • increases cost-effectiveness
  • supports development of biosimilars & biobetters
  • new options for life cycle management
  • barrier for me too and generics

Devices Functionalization Platform

More Information

Features

  • enables functionalized medical devices
  • allows for terminal sterilization at the end of manufacturing
  • for dry configurations of antibodies, vaccines in microneedles, growth factors, anti-microbials, etc.

Benefits

  • innovative medical devices by introducing biological functionality
  • improved shelf life
  • keeps established production processes including end-sterilization
  • cost-effective manufacturing